Trial Profile
Clinical study to investigate the efficiency of vascular occlusion prevention by ticagrelor after stent implantation in patients with peripheral artery disease (PAD) and high platelet reactivity during treatment with clopidogrel
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 14 May 2018
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Peripheral arterial disorders
- Focus Therapeutic Use
- Acronyms PAVK-TAH-Studie
- 09 May 2018 Status changed from recruiting to discontinued.
- 29 Dec 2014 New trial record